Rocatinlimab Does Not Impact Vaccination-Induced Immune Responses in Adults With Moderate-to-Severe Atopic Dermatitis: Results From the Phase 3 ROCKET-VOYAGER Trial
Fields of Study & Subjects
Dermatology and Skin Diseases
Asthma and respiratory diseases
SARS-CoV-2 and COVID-19 Research
Publication details
- Journal / source
- Journal of Allergy and Clinical Immunology
- Volume
- 157
- Issue
- 2
- Pages
- AB429–AB429
- Publication date
- 1 February 2026
- Language
- EN